| 中文名称 | 海柯吉宁 |
| 英文名称 | Hecogenin |
| CAS号 | 467-55-0 |
| 分子式 | C27H42O4 |
| 分子量 | 430.62 |
| EINECS号 | 207-392-4 |
| 熔点 | 268°C |
| 比旋光度 | 7.2 º (c=0.8 g/100ml, CHCl3) |
| 沸点 | 464.85°C (rough estimate) |
| 密度 | 1.0040 (rough estimate) |
| 折射率 | 1.4840 (estimate) |
| 溶解度 | 可溶于氯仿(少许)、甲醇(少许) |
| 形态 | 固体 |
| 酸度系数(pKa) | 15.10±0.70(Predicted) |
| 颜色 | 白色至类白色 |
| 默克索引编号 | 14,4622 |
| 海关编码 | 2937.29.9095 |
| Target | Value |
|
UGT1A4
() | 1.5 μM |
Hecogenin (3.1-90 mg/kg; oral administration; for 15 hours; male Swiss mice) acutely administered, before ethanol, exhibits a potent gastroprotective effect. The Hecogenin pretreatment normalizes GSH levels and significantly reduces lipid peroxidation and nitrite levels in the stomach, as evaluated by the ethanol-induced gastric lesion model. Hecogenin also decreases MPO release and significantly protects the gastric mucosa.
| Animal Model: | Male Swiss mice (20-30 g) with ethanol |
| Dosage: | 3.1 mg/kg, 7.5 mg/kg, 15 mg/kg, 30 mg/kg, 60 mg/kg and 90 mg/kg |
| Administration: | Oral administration; for 15 hours |
| Result: | Normalized GSH levels and significantly reduced lipid peroxidation and nitrite levels in the stomach, as evaluated by the ethanol-induced gastric lesion model. Decreased MPO release and significantly protected the gastric mucosa. |